Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A group of researchers, including Professor James FitzGerald from the Nuffield Department of Surgical Sciences, have published findings from its OxQUIP study looking at how eye movements are affected by medication in Parkinson's.

Professor Antoniades who is leading the OxQUIP Study said: 'There has been great interest in the precise measurement of abnormalities of eye movements as a way of determining the severity of Parkinson’s disease. We are delighted to be able to share the first results from this study and express our gratitude to our lovely patients for their enormous commitment and support'.

Read more (Nuffield Department of Clinical Neurosciences website)